中华器官移植杂志
中華器官移植雜誌
중화기관이식잡지
CHINESE JOURNAL OF ORGAN TRANSPLANTATION
2014年
4期
225-227
,共3页
朱幸沨%陈静瑜%郑明峰%何毅军%叶书高%刘峰
硃倖沨%陳靜瑜%鄭明峰%何毅軍%葉書高%劉峰
주행풍%진정유%정명봉%하의군%협서고%류봉
体外膜肺氧合%肺移植%凝血功能
體外膜肺氧閤%肺移植%凝血功能
체외막폐양합%폐이식%응혈공능
Extracorporeal membrane oxygenation%Lung transplantation%Coagulation
目的 观察应用体外膜肺氧合(ECMO)辅助转流对肺移植受者围手术期凝血功能的影响.方法 回顾性分析2007年1月至2012年3月接受双肺移植的受者40例,根据是否应用ECMO将受者分为ECMO组(28例)与对照组(12例),术中监测激活全血凝固时间,记录术中出血量,术后静脉采血检测血浆凝血酶原时间,活化部分凝血活酶时间,凝血时间及血浆纤维蛋白原等凝血功能指标.结果 ECMO组受者术中出血量为(1575.00±1631.56)ml、PT为(13.18±1.89)s、APII为(33.16±4.59)s及凝血时间为(18.05±1.65)s,对照组则分别为(1454.55±738.06) ml、(13.65±1.83)s、(33.76±8.41)s及(17.74±2.38)s,两组比较,差异均无统计学意义(P>0.05).术后ECMO组出现ECMO伤口感染2例,经治疗后好转出院,1例出现股动脉血栓形成,经溶栓治疗后好转出院.结论 肺移植围手术期使用ECMO未引起术中失血增多或术后凝血功能障碍,可提高手术成功率及改善预后,但有可能导致局部血栓形成的风险增加.
目的 觀察應用體外膜肺氧閤(ECMO)輔助轉流對肺移植受者圍手術期凝血功能的影響.方法 迴顧性分析2007年1月至2012年3月接受雙肺移植的受者40例,根據是否應用ECMO將受者分為ECMO組(28例)與對照組(12例),術中鑑測激活全血凝固時間,記錄術中齣血量,術後靜脈採血檢測血漿凝血酶原時間,活化部分凝血活酶時間,凝血時間及血漿纖維蛋白原等凝血功能指標.結果 ECMO組受者術中齣血量為(1575.00±1631.56)ml、PT為(13.18±1.89)s、APII為(33.16±4.59)s及凝血時間為(18.05±1.65)s,對照組則分彆為(1454.55±738.06) ml、(13.65±1.83)s、(33.76±8.41)s及(17.74±2.38)s,兩組比較,差異均無統計學意義(P>0.05).術後ECMO組齣現ECMO傷口感染2例,經治療後好轉齣院,1例齣現股動脈血栓形成,經溶栓治療後好轉齣院.結論 肺移植圍手術期使用ECMO未引起術中失血增多或術後凝血功能障礙,可提高手術成功率及改善預後,但有可能導緻跼部血栓形成的風險增加.
목적 관찰응용체외막폐양합(ECMO)보조전류대폐이식수자위수술기응혈공능적영향.방법 회고성분석2007년1월지2012년3월접수쌍폐이식적수자40례,근거시부응용ECMO장수자분위ECMO조(28례)여대조조(12례),술중감측격활전혈응고시간,기록술중출혈량,술후정맥채혈검측혈장응혈매원시간,활화부분응혈활매시간,응혈시간급혈장섬유단백원등응혈공능지표.결과 ECMO조수자술중출혈량위(1575.00±1631.56)ml、PT위(13.18±1.89)s、APII위(33.16±4.59)s급응혈시간위(18.05±1.65)s,대조조칙분별위(1454.55±738.06) ml、(13.65±1.83)s、(33.76±8.41)s급(17.74±2.38)s,량조비교,차이균무통계학의의(P>0.05).술후ECMO조출현ECMO상구감염2례,경치료후호전출원,1례출현고동맥혈전형성,경용전치료후호전출원.결론 폐이식위수술기사용ECMO미인기술중실혈증다혹술후응혈공능장애,가제고수술성공솔급개선예후,단유가능도치국부혈전형성적풍험증가.
Objective To observe the effects of extracorporeal membrane oxygenation (ECMO) on coagulation during lung trangplantation.Method Forty cases of end stage lung diseases received bilateral sequential single lung transplantation during July 2007 and Mar.2012.The patients were divided into two groups in terms of ECMO.ECMO was applied before lung transplantation if needed.The amount of bleeding during surgery was recorded.The venous blood samples were collected during and after operation for the measurements of the following parameters:activated whole blood clot time (ACT),prothrombin time (PT),activated partial thromboplastin time (APTT),thrombin time (TT) and plasma fibrinogen (Fg).Result The coagulation and the amount of bleeding showed no significant difference between the two groups.Wound infection occurred in 2 patients where the ECMO tube was inserted and femoral arterial thrombosis in one patient.All of the three patients were cured and discharged.Conclusion ECMO didn't cause excessive bleeding or coagulation dysfunction during lung transplantation,yet it maybe increase the occurrence of local thrombosis.